Introduction: Norepinephrine, a prototype direct acting sympathomimetic, is essential in pharmacology teaching for B. Pharm students. This neurotransmitter and drug predominantly stimulates alpha‑adrenergic and beta‑1 receptors, producing vasoconstriction, increased peripheral resistance, and raised blood pressure. Understanding its mechanism of action, receptor selectivity, metabolism (MAO/COMT), clinical uses, adverse effects, and drug interactions is crucial for safe therapeutic use. These focused MCQs on Direct acting sympathomimetics – Norepinephrine MCQs With Answer will reinforce key concepts in cardiovascular pharmacology, clinical scenarios, and rational drug application. Now let’s test your knowledge with 50 MCQs on this topic.
Q1. Which receptors are primarily activated by intravenous norepinephrine?
- Alpha-1 and Beta-1 receptors
- Beta-2 and Beta-3 receptors
- Muscarinic receptors
- Dopamine D2 receptors
Correct Answer: Alpha-1 and Beta-1 receptors
Q2. The main clinical indication for intravenous norepinephrine is:
- Septic shock with refractory hypotension
- Chronic asthma maintenance
- Treatment of bradycardia in stable patients
- Oral management of hypertension
Correct Answer: Septic shock with refractory hypotension
Q3. Which hemodynamic effect is most characteristic after norepinephrine administration?
- Marked increase in systemic vascular resistance
- Marked decrease in systemic vascular resistance
- Significant bronchodilation
- Profound diuresis
Correct Answer: Marked increase in systemic vascular resistance
Q4. A common reflex response to the blood pressure rise after norepinephrine is:
- Reflex bradycardia due to baroreceptor activation
- Reflex tachycardia due to baroreceptor activation
- Increased respiratory rate
- Vasodilation in skeletal muscle
Correct Answer: Reflex bradycardia due to baroreceptor activation
Q5. Norepinephrine is metabolized primarily by which enzymes?
- Monoamine oxidase (MAO) and catechol‑O‑methyltransferase (COMT)
- CYP3A4 and CYP2D6
- Acetylcholinesterase and butyrylcholinesterase
- Alkaline phosphatase and esterases
Correct Answer: Monoamine oxidase (MAO) and catechol‑O‑methyltransferase (COMT)
Q6. Compared with epinephrine, norepinephrine has relatively less activity at:
- Beta-2 receptors
- Alpha-1 receptors
- Beta-1 receptors
- Alpha-2 receptors
Correct Answer: Beta-2 receptors
Q7. The most important contraindication for norepinephrine infusion is:
- Mesenteric or peripheral vascular thrombosis leading to severe ischemia
- Mild seasonal allergic rhinitis
- Controlled hypothyroidism
- Stable angina under control
Correct Answer: Mesenteric or peripheral vascular thrombosis leading to severe ischemia
Q8. Extravasation of norepinephrine can cause tissue necrosis due to:
- Local vasoconstriction and ischemia
- Bacterial contamination of the IV line
- Immune complex deposition
- Direct enzymatic tissue digestion
Correct Answer: Local vasoconstriction and ischemia
Q9. Which of the following drug interactions increases response to norepinephrine?
- MAO inhibitors (MAOIs)
- Beta blockers
- Alpha blockers
- Antacids
Correct Answer: MAO inhibitors (MAOIs)
Q10. The primary route of administration for therapeutic norepinephrine is:
- Intravenous infusion
- Oral tablet
- Subcutaneous injection for long-term use
- Inhalation
Correct Answer: Intravenous infusion
Q11. Which intracellular signaling pathway is activated by alpha-1 adrenergic receptors stimulated by norepinephrine?
- Gq → phospholipase C → increased IP3 and DAG
- Gs → increased cAMP
- Gi → decreased cAMP
- Tyrosine kinase phosphorylation cascade
Correct Answer: Gq → phospholipase C → increased IP3 and DAG
Q12. Which electrophysiological adverse effect may occur with high doses of norepinephrine?
- Cardiac arrhythmias
- Complete heart block always
- Prolonged QT interval without arrhythmia
- Ventricular atrophy
Correct Answer: Cardiac arrhythmias
Q13. Norepinephrine has limited use in anaphylactic shock because:
- It lacks significant beta-2 mediated bronchodilation compared to epinephrine
- It causes excessive bronchodilation worsening symptoms
- It is contraindicated in allergic reactions
- It leads to histamine release
Correct Answer: It lacks significant beta-2 mediated bronchodilation compared to epinephrine
Q14. The transporter responsible for norepinephrine reuptake into presynaptic nerve terminals is:
- Norepinephrine transporter (NET/uptake-1)
- Serotonin transporter (SERT)
- Glutamate transporter (EAAT)
- P-glycoprotein efflux pump
Correct Answer: Norepinephrine transporter (NET/uptake-1)
Q15. In a biphase dose-response, increasing norepinephrine dose primarily increases:
- Vasoconstriction via alpha-1 receptors then modest beta-1 cardiac effects
- Bronchodilation via beta-2 receptors primarily
- Diuresis and natriuresis via renal alpha receptors
- Insulin secretion from pancreatic beta cells
Correct Answer: Vasoconstriction via alpha-1 receptors then modest beta-1 cardiac effects
Q16. Compared to dopamine, norepinephrine is more effective at:
- Raising systemic vascular resistance in septic shock
- Increasing renal blood flow at low doses
- Stimulating dopaminergic receptors to increase urine output
- Producing bronchodilation
Correct Answer: Raising systemic vascular resistance in septic shock
Q17. Which of the following clinical monitoring parameters is most important during a norepinephrine infusion?
- Continuous blood pressure and heart rate monitoring
- Serum glucose every 5 minutes
- Pulmonary function testing hourly
- Ophthalmic examination daily
Correct Answer: Continuous blood pressure and heart rate monitoring
Q18. The term “direct acting sympathomimetic” means the drug:
- Directly stimulates adrenergic receptors
- Promotes endogenous norepinephrine release only
- Acts by blocking adrenergic receptors
- Inhibits monoamine oxidase to increase catecholamines
Correct Answer: Directly stimulates adrenergic receptors
Q19. Which pharmacokinetic property of norepinephrine makes oral administration ineffective?
- Poor oral bioavailability due to extensive first‑pass metabolism by MAO/COMT
- Excellent oral absorption but extreme renal excretion
- High lipid solubility causing sequestration in fat
- Long half-life leading to accumulation orally
Correct Answer: Poor oral bioavailability due to extensive first‑pass metabolism by MAO/COMT
Q20. Which sign suggests excessive alpha-1 mediated vasoconstriction from norepinephrine?
- Cold, pale extremities and decreased capillary refill
- Warm flushed skin and sweating
- Prominent bronchodilation and wheeze
- Polyuria and polydipsia
Correct Answer: Cold, pale extremities and decreased capillary refill
Q21. Co-administration of norepinephrine with a nonselective beta blocker is likely to cause:
- Exaggerated hypertension due to unopposed alpha stimulation
- Marked hypotension due to beta blockade of vascular tone
- Severe bronchospasm improvement
- Potentiation of dopamine effects
Correct Answer: Exaggerated hypertension due to unopposed alpha stimulation
Q22. Which laboratory finding may be seen after prolonged high‑dose norepinephrine therapy?
- Elevated lactate from tissue hypoperfusion
- Marked hypoglycemia due to insulin release
- Persistent hyperkalemia due to beta-2 activation
- Reduction in creatinine kinase levels
Correct Answer: Elevated lactate from tissue hypoperfusion
Q23. In the context of receptor pharmacology, norepinephrine is best described as:
- A full agonist at alpha-1 and beta-1 receptors
- An antagonist at alpha receptors
- A partial agonist at beta-2 receptors
- An inverse agonist at beta-1 receptors
Correct Answer: A full agonist at alpha-1 and beta-1 receptors
Q24. Which clinical situation favors use of norepinephrine over phenylephrine?
- Hypotension with associated myocardial depression where some beta-1 support is desired
- Pure reflex tachycardia needing only alpha blockade
- Severe bronchospasm requiring beta-2 agonism
- Chronic hypertension management orally
Correct Answer: Hypotension with associated myocardial depression where some beta-1 support is desired
Q25. The recommended immediate treatment for norepinephrine extravasation is:
- Phentolamine injection locally to counteract alpha-mediated vasoconstriction
- Oral beta blocker to reduce heart rate
- Warm compresses only without pharmacologic intervention
- Systemic glucocorticoids to reduce inflammation
Correct Answer: Phentolamine injection locally to counteract alpha-mediated vasoconstriction
Q26. Which receptor subtype mediates vasoconstriction in most vascular beds when activated by norepinephrine?
- Alpha-1 adrenergic receptors
- Beta-2 adrenergic receptors
- Muscarinic M3 receptors
- Dopamine D1 receptors
Correct Answer: Alpha-1 adrenergic receptors
Q27. In adrenergic receptor signaling, stimulation of beta-1 receptors primarily leads to:
- Increased heart rate and contractility via Gs and cAMP
- Smooth muscle contraction via Gq and IP3
- Decreased cAMP via Gi leading to relaxation
- Activation of tyrosine kinase receptors
Correct Answer: Increased heart rate and contractility via Gs and cAMP
Q28. Which patient factor increases risk of adverse cardiac effects with norepinephrine?
- Pre-existing ischemic heart disease
- Young healthy athlete
- Mild eczema
- Well-controlled hypothyroidism
Correct Answer: Pre-existing ischemic heart disease
Q29. Which statement about norepinephrine and cerebral circulation is correct?
- Cerebral autoregulation usually maintains cerebral blood flow despite increased systemic BP
- Norepinephrine causes immediate cerebral vasodilation raising intracranial pressure always
- Cerebral blood flow falls proportionally and irreversibly with norepinephrine
- Norepinephrine directly crosses the blood-brain barrier to stimulate central receptors easily
Correct Answer: Cerebral autoregulation usually maintains cerebral blood flow despite increased systemic BP
Q30. Which adverse metabolic effect may occur during norepinephrine infusion?
- Hyperglycemia due to hepatic glycogenolysis and decreased insulin release
- Profound hypoglycemia due to increased insulin secretion
- Marked hypertriglyceridemia within minutes
- Severe hyponatremia due to SIADH
Correct Answer: Hyperglycemia due to hepatic glycogenolysis and decreased insulin release
Q31. A B. Pharm student studying drug interactions should note that tricyclic antidepressants (TCAs) when combined with norepinephrine can:
- Potentiate hypertensive effects by blocking norepinephrine reuptake
- Eliminate all alpha receptor effects
- Prevent norepinephrine metabolism by COMT directly
- Reduce norepinephrine plasma levels by inducing MAO
Correct Answer: Potentiate hypertensive effects by blocking norepinephrine reuptake
Q32. Which experimental observation supports norepinephrine acting as a direct agonist rather than an indirect releaser?
- It produces effects in denervated tissues lacking sympathetic nerve terminals
- It fails to produce any response in intact tissues
- It only works when presynaptic vesicular release is intact
- Its effects are blocked by vesicular monoamine transporter inhibitors only
Correct Answer: It produces effects in denervated tissues lacking sympathetic nerve terminals
Q33. In emergency settings, titration of norepinephrine dose is guided primarily by:
- Target mean arterial pressure (MAP)
- Plasma norepinephrine concentration every minute
- Liver enzyme levels
- Pupil size changes
Correct Answer: Target mean arterial pressure (MAP)
Q34. Which receptor contributes to feedback inhibition of norepinephrine release when activated?
- Alpha-2 adrenergic autoreceptors on presynaptic terminals
- Beta-3 receptors on adipocytes
- Muscarinic M2 receptors on myocardium
- NMDA receptors in CNS
Correct Answer: Alpha-2 adrenergic autoreceptors on presynaptic terminals
Q35. What effect would a selective alpha-1 antagonist have on norepinephrine-induced blood pressure changes?
- It would reduce the vasoconstrictor (blood pressure) response
- It would enhance vasoconstriction and raise BP more
- It would convert norepinephrine into an antagonist
- It would increase norepinephrine metabolism by COMT
Correct Answer: It would reduce the vasoconstrictor (blood pressure) response
Q36. Which clinical lab value may indicate end-organ hypoperfusion during excessive vasoconstriction from norepinephrine?
- Rising serum creatinine indicating renal hypoperfusion
- Decreasing hemoglobin within minutes
- Very low serum sodium due to sweat loss
- Immediate normalization of liver enzymes
Correct Answer: Rising serum creatinine indicating renal hypoperfusion
Q37. Norepinephrine’s effect on pulmonary circulation is best described as:
- Minimal direct bronchodilation but can increase pulmonary vascular resistance
- Major bronchodilation via beta-2 receptors
- Significant decrease in pulmonary vascular resistance in all cases
- Primary stimulation of surfactant production in alveoli
Correct Answer: Minimal direct bronchodilation but can increase pulmonary vascular resistance
Q38. Which statement about tolerance or tachyphylaxis to norepinephrine is true?
- Prolonged exposure can lead to receptor desensitization reducing responsiveness
- Tolerance never develops to catecholamines
- Tolerance is immediate and irreversible after first dose
- Tolerance enhances alpha receptor signaling over time
Correct Answer: Prolonged exposure can lead to receptor desensitization reducing responsiveness
Q39. In adrenergic pharmacology, the term “pressor effect” refers to:
- An increase in arterial blood pressure
- A decrease in systemic vascular resistance
- Reduction of myocardial contractility
- Anesthetic-induced hypotension
Correct Answer: An increase in arterial blood pressure
Q40. Which of these drugs is most appropriate to reverse severe norepinephrine-induced vasoconstriction systemically?
- Phentolamine (nonselective alpha antagonist)
- Propranolol (nonselective beta blocker)
- Salbutamol (beta-2 agonist inhaler)
- Furosemide (loop diuretic)
Correct Answer: Phentolamine (nonselective alpha antagonist)
Q41. Which patient population requires careful dosing and monitoring when using norepinephrine?
- Patients with peripheral vascular disease and diabetes
- Young athletes with no comorbidity
- Patients with seasonal allergies only
- Individuals on topical antifungal therapy
Correct Answer: Patients with peripheral vascular disease and diabetes
Q42. Which experimental assay would demonstrate norepinephrine activation of beta-1 receptors in cardiomyocytes?
- Increased intracellular cAMP levels following drug application
- Reduced intracellular calcium below baseline
- Inhibition of adenylate cyclase activity
- Activation of phospholipase C with increased IP3 only
Correct Answer: Increased intracellular cAMP levels following drug application
Q43. Which statement correctly contrasts norepinephrine and isoproterenol?
- Isoproterenol is a nonselective beta agonist causing marked tachycardia and vasodilation, while norepinephrine is alpha-1 dominant
- Isoproterenol primarily stimulates alpha-1 receptors while norepinephrine is beta-2 selective
- Both drugs are identical in receptor selectivity and clinical use
- Norepinephrine causes bronchodilation equal to isoproterenol
Correct Answer: Isoproterenol is a nonselective beta agonist causing marked tachycardia and vasodilation, while norepinephrine is alpha-1 dominant
Q44. Which monitoring method helps detect limb ischemia early during norepinephrine therapy?
- Frequent peripheral perfusion checks and capillary refill assessment
- Daily chest X-ray
- Serum magnesium measurement hourly
- 24-hour Holter monitoring only
Correct Answer: Frequent peripheral perfusion checks and capillary refill assessment
Q45. In pharmacology exams, why is norepinephrine considered more “vasopressor” than “inotrope”?
- Because its alpha‑mediated vasoconstrictive effects dominate over beta‑1 cardiac stimulation at therapeutic doses
- Because it only acts on muscarinic receptors to reduce heart rate
- Because it has no effect on heart contractility whatsoever
- Because it is primarily used as an oral antihypertensive
Correct Answer: Because its alpha‑mediated vasoconstrictive effects dominate over beta‑1 cardiac stimulation at therapeutic doses
Q46. Which adverse event is a direct consequence of excessive beta-1 stimulation by norepinephrine?
- Increased myocardial oxygen demand and potential ischemia
- Profound sedation
- Marked peripheral edema due to antidiuretic hormone release
- Hyperpigmentation of the skin
Correct Answer: Increased myocardial oxygen demand and potential ischemia
Q47. For B. Pharm students, which formulation detail is essential for safe hospital use of norepinephrine?
- It is supplied for IV infusion and requires dilution and infusion pump control
- It is typically available as an oral sustained-release tablet
- It is administered intramuscularly for long-term therapy
- It is best given as an over-the-counter nasal spray
Correct Answer: It is supplied for IV infusion and requires dilution and infusion pump control
Q48. Which physiologic effect helps maintain coronary perfusion during norepinephrine use despite increased heart rate?
- Reflex bradycardia may limit tachycardia and improve diastolic filling time
- Massive coronary vasodilation via beta-2 receptors
- Suppression of cardiac oxygen demand by alpha-2 activation
- Immediate increase in hemoglobin concentration
Correct Answer: Reflex bradycardia may limit tachycardia and improve diastolic filling time
Q49. Which statement about norepinephrine’s penetration into the CNS is correct?
- It poorly crosses the blood-brain barrier, limiting central effects
- It easily accumulates in CNS causing marked central stimulation at low doses
- It is the primary catecholamine used for treating depression centrally
- Its central effects are equivalent to oral caffeine
Correct Answer: It poorly crosses the blood-brain barrier, limiting central effects
Q50. Which is an appropriate academic test question for B. Pharm students to evaluate understanding of norepinephrine pharmacology?
- Explain receptor selectivity, clinical indications, metabolic pathways, adverse effects, and management of extravasation for norepinephrine
- List all antibiotics that interact with norepinephrine without explanation
- Describe how to formulate an oral norepinephrine syrup for outpatient use
- Compare norepinephrine to vitamin supplements in dietary therapy
Correct Answer: Explain receptor selectivity, clinical indications, metabolic pathways, adverse effects, and management of extravasation for norepinephrine
